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Background: Limited data are available on the optimal treatment of women with unprotected left main coronary artery (ULMCA) disease. The aim 
was to specifically evaluate long-term clinical outcomes in women treated with percutaneous coronary intervention (PCI) with drug-eluting stents 
(DES) vs. coronary artery bypass grafting (CABG).
methods: All consecutive women from the Drug Eluting stent for LefT main coronary Artery disease (DELTA) Registry with ULMCA disease treated by 
PCI with DES or CABG were analyzed. A propensity matching was performed to adjust for baseline differences between the 2 treatment groups.
results: In total, 818 women were included: 489 (59.8%) underwent treatment with PCI with DES vs. 329 (40.2%) with CABG. Propensity score 
matching identified 176 matched pairs of patients, with no differences in the primary study objective of death, myocardial infarction (MI) or 
cerebrovascular accident (CVA) (Hazard Ratio [HR] 0.711; 95% Confidence Interval [CI] 0.387-1.308; p=0.273), all-cause (HR 0.722; 95% CI 
0.357-1.461; p=0.365) or cardiovascular mortality (HR 1.100; 95% CI 0.455-2.660; p=0.832), MI (HR 0.362; 95% CI 0.094-1.388) or CVA (HR 
1.200; 95% CI 0.359-4.007; p=0.767). However, there was an advantage of CABG over PCI in major adverse cardiovascular and cerebrovascular 
events (MACCE) (HR 0.429; 95% CI 0.254-0.723; p=0.001), driven exclusively by target vessel revascularization (TVR) (HR 0.185; 95% CI 0.079-
0.432; p<0.001).
conclusions: In women with significant ULMCA disease, no difference was observed in death, MI and stroke at long term follow-up. However, 
repeat revascularization remained higher in the PCI cohort.
